BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11354700)

  • 1. 25 years' experience with the Biken Oka strain varicella vaccine: a clinical overview.
    Takahashi M
    Paediatr Drugs; 2001; 3(4):285-92. PubMed ID: 11354700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worldwide experience with the Oka-strain live varicella vaccine.
    Andre FE
    Postgrad Med J; 1985; 61 Suppl 4():113-20. PubMed ID: 3014468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicella vaccination of children in the United States: assessment after the first decade 1995-2005.
    Grose C
    J Clin Virol; 2005 Jun; 33(2):89-95; discussion 96-8. PubMed ID: 15911422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella vaccination in Japan: necessity of implementing a routine vaccination program.
    Ozaki T
    J Infect Chemother; 2013 Apr; 19(2):188-95. PubMed ID: 23483311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.
    Ozaki T
    Vaccine; 2013 Dec; 31(51):6155-60. PubMed ID: 24183712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella vaccine: the Japanese experience.
    Asano Y
    J Infect Dis; 1996 Nov; 174 Suppl 3():S310-3. PubMed ID: 8896537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of a second dose of varicella vaccine administered at 4 to 6 years of age in healthy children in Argentina.
    Fridman D; Monti A; Bonnet MC; Armoni J; Stamboulian D
    Hum Vaccin; 2011 Oct; 7(10):1066-71. PubMed ID: 21989288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
    Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
    Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with Oka live varicella vaccine in Japan.
    Takahashi M; Kamiya H; Baba K; Asano Y; Ozaki T; Horiuchi K
    Postgrad Med J; 1985; 61 Suppl 4():61-7. PubMed ID: 3014479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
    Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is vaccination against varicella efficacious and how long does the protection last?].
    Ołdak E
    Med Wieku Rozwoj; 2013; 17(4):341-6. PubMed ID: 24519777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Varicella vaccination].
    Senterre J
    Rev Med Brux; 2004 Sep; 25(4):A223-6. PubMed ID: 15516045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of varicella vaccination in children in Germany: a case-control study.
    Liese JG; Cohen C; Rack A; Pirzer K; Eber S; Blum M; Greenberg M; Streng A
    Pediatr Infect Dis J; 2013 Sep; 32(9):998-1004. PubMed ID: 23694831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group.
    Choi UY; Huh DH; Kim JH; Kang JH
    Hum Vaccin Immunother; 2016 Oct; 12(10):2560-2564. PubMed ID: 27484734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of vaccine-induced immunity to varicella over time.
    Chaves SS; Gargiullo P; Zhang JX; Civen R; Guris D; Mascola L; Seward JF
    N Engl J Med; 2007 Mar; 356(11):1121-9. PubMed ID: 17360990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.
    Macartney K; McIntyre P
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001833. PubMed ID: 18646079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
    Naganuma Y; Osawa S; Takahashi R
    Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.